Ads
related to: sickle cell anemia and malaria- Treatment Journey
See the treatment journey
Step by step.
- Treatment Journey Video
See the treatment journey
video on the HCP website.
- Resources
Downloadable HCP brochure
and more professional resources.
- About The Therapy
The science behind the disease
and this treatment option.
- Mechanism of Action Video
Watch an MOA video on the
official HCP website.
- Stay Informed
Sign up to receive updates
as they become available.
- Treatment Journey
- 5650 Blazer Parkway, Dublin, OH · Directions · (614) 408-8783
Search results
Results From The WOW.Com Content Network
While malaria is still affecting the regular cells (2), the ratio of sickle to regular cells is 50/50 due to sickle cell anemia being a heterozygous trait, so the malaria cannot affect enough cells with schizonts (5) to harm the body.
Sickle cell disease (SCD), also simply called sickle cell, is a group of hemoglobin-related blood disorders typically inherited. The most common type is known as sickle cell anemia. It results in an abnormality in the oxygen-carrying protein haemoglobin found in red blood cells.
The sickle cell trait provides a survival advantage against malaria fatality over people with normal hemoglobin in regions where malaria is endemic. The trait is known to cause significantly fewer deaths due to malaria, especially when Plasmodium falciparum is the causative organism.
The impact of sickle cell trait on malaria immunity illustrates some evolutionary trade-offs that have occurred because of endemic malaria. Sickle cell trait causes a change in the haemoglobin molecule in the blood.
Sickle-cell anemia (SCA) is a genetic disorder caused by the presence of two incompletely recessive alleles. When a sufferer's red blood cells are exposed to low- oxygen conditions, the cells lose their healthy round shape and become sickle-shaped.
Several genetic factors provide some resistance to Plasmodium infection, including sickle cell trait, thalassaemia traits, glucose-6-phosphate dehydrogenase deficiency, and the absence of Duffy antigens on red blood cells.
His final results reported in 1954 from nearly 5,000 East Africans indicated the overall picture: sickle-cell trait confers resistance to malaria. When Allison introduced the genetic theory of malaria resistance, it was largely received with scepticism.
A similar relationship exists between malaria and sickle-cell disease. One theory to explain this is that cells infected with the Plasmodium parasite are cleared more rapidly by the spleen . This phenomenon might give G6PD deficiency carriers an evolutionary advantage by increasing their fitness in malarial endemic environments.
Schistocytes on the peripheral blood smear is a characteristic feature of microangiopathic hemolytic anemia (MAHA). The causes of MAHA can be disseminated intravascular coagulation , thrombotic thrombocytopenic purpura , hemolytic-uremic syndrome , HELLP syndrome , malfunctioning cardiac valves etc.
An example of overdominance in humans is that of the sickle cell anemia. This condition is determined by a single polymorphism. Possessors of the deleterious allele have lower life expectancy, with homozygotes rarely reaching 50 years of age. However, this allele also yields some resistance to malaria.
Ads
related to: sickle cell anemia and malaria- 5650 Blazer Parkway, Dublin, OH · Directions · (614) 408-8783
